Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form ...
Protalix announces positive 12-month interim data from BRIDGE phase III study of pegunigalsidase alfa to treat fabry disease: Carmiel, Israel Friday, October 18, 2019, 18:00 Hrs [ ...
Having made adjustments worth R4.2-billion to its Rosslyn-based production plant to accommodate for plug-in hybrid electric vehicle (PHEV) manufacturing since October last year, automotive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback